{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T17:04:48Z","timestamp":1791219888046,"version":"4.1.0"},"reference-count":40,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T00:00:00Z","timestamp":1700438400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The systemic immune-inflammation index (SII) is a cost-efficient indicator for carcinoma prognosis. However, its utility in urothelial carcinoma (UC) prognosis is disputed. This meta-analysis aims to assess SII\u2019s prognostic value in UC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A thorough search of databases including PubMed, Web of Science, Embase, Cochrane Library, and Scopus, was conducted to find studies until January 11, 2023. Eligibility criteria were applied to select studies. Hazard ratios (HRs) and 95% confidence intervals (CIs) were extracted from selected studies and compiled in a meta-analysis to gauge SII\u2019s association with survival outcomes such as overall survival (OS), cancer-specific survival (CSS), recurrence-free survival (RFS), and progression-free survival (PFS).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>This analysis includes 19 studies with 12505 UC patients. It was found that high SII significantly correlated with worse OS in UC patients (HR 1.430, 95% CI 1.237-1.653, P&amp;lt;0.001). High SII values also linked with poorer CSS (HR 1.913, 95% CI 1.473-2.485, P&amp;lt;0.001), RFS (HR 1.240, 95% CI 1.097-1.403, P=0.001), and PFS (HR 1.844, 95% CI 1.488-2.284, P&amp;lt;0.001) compared to low SII values. Subgroup analysis revealed SII\u2019s consistent prognostic value in UC across races, carcinoma types, sample sizes, and SII cut-off values, suggesting its potential as a prognostic indicator in UC patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Current evidence suggests SII as a promising, cost-efficient predictor in UC patients. This meta-analysis indicates SII\u2019s potential as a valuable prognostic tool in UC patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Systematic review registration<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link>https:\/\/www.crd.york.ac.uk\/PROSPERO\/display_record.php?RecordID=307643<\/jats:ext-link>\n                      , identifier CRD42022307643.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2023.1275033","type":"journal-article","created":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T23:27:11Z","timestamp":1700436431000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":32,"title":["Preoperative systemic immune-inflammation index as a prognostic indicator for patients with urothelial carcinoma"],"prefix":"10.3389","volume":"14","author":[{"given":"Jianxiong","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaohua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyang","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayao","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haili","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,11,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.pathol.2020.09.004","article-title":"Urothelial carcinoma: variant histology, molecular subtyping, and immunophenotyping significant for treatment outcomes","volume":"53","author":"Takahara","year":"2021","journal-title":"Pathology"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"B3","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21654","article-title":"Cancer statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-022-04219-5","article-title":"Upper tract urothelial carcinoma in Germany: epidemiological data and surgical treatment trends in a total population analysis from 2006 to 2019","volume":"41","author":"Herout","year":"2022","journal-title":"World J Urol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.euf.2019.09.003","article-title":"What is the significance of variant histology in urothelial carcinoma","volume":"6","author":"Lobo","year":"2020","journal-title":"Eur Urol Focus"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.21037\/tau.2019.11.22","article-title":"Epidemiology, clinical presentation, and evaluation of upper-tract urothelial carcinoma","volume":"9","author":"Petros","year":"2020","journal-title":"Transl Androl Urol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/nature07205","article-title":"Cancer-related inflammation","volume":"454","author":"Mantovani","year":"2008","journal-title":"Nature"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.cub.2020.06.081","article-title":"The tumor microenvironment","volume":"30","author":"Anderson","year":"2020","journal-title":"Curr Biol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ucl.2020.10.005","article-title":"The tumor microenvironment and immunotherapy in prostate and bladder cancer","volume":"47","author":"Nair","year":"2020","journal-title":"Urol Clin North Am"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24065846","article-title":"Blood-based biomarkers as prognostic factors of recurrent disease after radical cystectomy: A systematic review and meta-analysis","volume":"24","author":"Ofner","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-021-02884-w","article-title":"Prognostic role of the systemic immune\u2013inflammation index in upper tract urothelial carcinoma treated with radical nephroureterectomy: results from a large multicenter international collaboration","volume":"70","author":"Mori","year":"2021","journal-title":"Cancer Immunology Immunotherapy"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.21037\/atm-21-4097","article-title":"Development of nomograms related to inflammatory biomarkers to estimate the prognosis of bladder cancer after radical cystectomy","volume":"9","author":"Zhang","year":"2021","journal-title":"Ann Transl Med"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/9234067","article-title":"Diagnostic and predictive values of inflammatory factors in pathology and survival of patients undergoing total cystectomy","volume":"2020","author":"Tang","year":"2020","journal-title":"Mediators Inflammation"},{"key":"B14","doi-asserted-by":"publisher","first-page":"431","DOI":"10.21037\/atm.2019.09.02","article-title":"Systemic immune-inflammation index predicts prognosis of bladder cancer patients after radical cystectomy","volume":"7","author":"Zhang","year":"2019","journal-title":"Ann Transl Med"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1007\/s10147-021-02088-3","article-title":"Preoperative models incorporating the systemic immune-inflammation index for predicting prognosis and muscle invasion in patients with non-metastatic upper tract urothelial carcinoma","volume":"27","author":"Kobayashi","year":"2022","journal-title":"Int J Clin Oncol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"Bmj"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1007\/s10654-010-9491-z","article-title":"Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses","volume":"25","author":"Stang","year":"2010","journal-title":"Eur J Epidemiol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnu.2021.10.019","article-title":"Preoperative abdominal fat distribution and systemic immune inflammation were associated with response to intravesical Bacillus Calmette-Guerin immunotherapy in patients with non-muscle invasive bladder cancer","volume":"40","author":"Ke","year":"2021","journal-title":"Clin Nutr"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1032907","article-title":"Preoperative sarcopenia and systemic immune-inflammation index can predict response to intravesical Bacillus Calmette-Guerin instillation in patients with non-muscle invasive bladder cancer","volume":"13","author":"Liu","year":"2022","journal-title":"Front Immunol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S259117","article-title":"Predictive values of preoperative prognostic nutritional index and systemic immune-inflammation index for long-term survival in high-risk non-muscle-invasive bladder cancer patients: A single-centre retrospective study","volume":"12","author":"Bi","year":"2020","journal-title":"Cancer Manag Res"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10225273","article-title":"The predictive value of systemic immune-inflammation index on bladder recurrence on upper tract urothelial carcinoma outcomes after radical nephroureterectomy","volume":"10","author":"Chien","year":"2021","journal-title":"J Clin Med"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2021.100118","article-title":"Immune-inflammatory biomarkers as prognostic factors for immunotherapy in pretreated advanced urinary tract cancer patients: an analysis of the Italian SAUL cohort","volume":"6","author":"Fornarini","year":"2021","journal-title":"Esmo Open"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-018-6942-3","article-title":"Combination of the preoperative systemic immune-inflammation index and monocyte-lymphocyte ratio as a novel prognostic factor in patients with upper-tract urothelial carcinoma","volume":"26","author":"Jan","year":"2019","journal-title":"Ann Surg Oncol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-021-03740-3","article-title":"Prognostic value of the systemic immune-inflammation index in non-muscle invasive bladder cancer","volume":"39","author":"Katayama","year":"2021","journal-title":"World J Urol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.2217\/bmm-2020-0045","article-title":"The prognostic significance of hemoglobin-to-red cell distribution width ratio in muscle-invasive bladder cancer","volume":"14","author":"Yilmaz","year":"2020","journal-title":"biomark Med"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.23883","article-title":"The predictive value of the ratio of the product of neutrophils and hemoglobin to lymphocytes in non-muscular invasive bladder cancer patients with postoperative recurrence","volume":"35","author":"Zhao","year":"2021","journal-title":"J Clin Lab Anal"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.7150\/jca.44915","article-title":"Association of preoperative systemic Immune-inflammation Index and Prognostic Nutritional Index with survival in patients with Upper Tract Urothelial Carcinoma","volume":"11","author":"Zheng","year":"2020","journal-title":"J Cancer"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics11122194","article-title":"Usefulness of preoperative high systemic immune-inflammation index as a prognostic biomarker in patients who undergo radical cystectomy for bladder cancer: multicenter analysis","volume":"11","author":"Yamashita","year":"2021","journal-title":"Diagnostics (Basel)"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.urolonc.2021.10.006","article-title":"Impact of preoperative systemic immune-inflammation Index on oncologic outcomes in bladder cancer patients treated with radical cystectomy","volume":"40","author":"Grossmann","year":"2022","journal-title":"Urologic Oncology: Semin Original Investigations"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1072433","article-title":"The prognostic value of the systemic immune-inflammation index for patients with bladder cancer after radical cystectomy","volume":"13","author":"Zhang","year":"2022","journal-title":"Front Immunol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.clgc.2022.11.013","article-title":"Systemic immune-inflammation index (SII) during induction has higher predictive value than preoperative SII in non-muscle-invasive bladder cancer patients receiving intravesical bacillus calmette -guerin","volume":"21","author":"Deng-xiong","year":"2022","journal-title":"Clin Genitourin Cancer"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.5501","article-title":"Preoperative systemic immune-inflammation index as a significant prognostic factor afterTURBT in patients with non-muscle-invasive bladder cancer: A retrospective study based on propensity score matching analysis","volume":"12","author":"Ding","year":"2022","journal-title":"Cancer Med"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2015.10.024","article-title":"Economic burden of bladder cancer across the European Union","volume":"69","author":"Leal","year":"2016","journal-title":"Eur Urol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"376","DOI":"10.3322\/caac.21765","article-title":"Cancer epigenetics in clinical practice","volume":"73","author":"Davalos","year":"2022","journal-title":"CA Cancer J Clin"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000013788","article-title":"Systemic immune-inflammation index is a promising noninvasive marker to predict survival of lung cancer: A meta-analysis","volume":"98","author":"Zhang","year":"2019","journal-title":"Med (Baltimore)"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/6988489","article-title":"Prognostic and clinical value of the systemic immune-inflammation index in biliary tract cancer: A meta-analysis","volume":"2022","author":"Peng","year":"2022","journal-title":"J Immunol Res"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.26355\/eurrev_202102_24834","article-title":"Prognostic value of systemic immune-inflammation index in patients with urinary system cancers: a meta-analysis","volume":"25","author":"Wang","year":"2021","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.865643","article-title":"The prognostic and clinicopathological significance of systemic immune-inflammation index in bladder cancer","volume":"13","author":"Li","year":"2022","journal-title":"Front Immunol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1097\/MD.000000000003038010.3389\/fimmu.2022.865643","article-title":"Prognostic significance of systemic immune-inflammation index in patients with bladder cancer: A systematic review and meta-analysis","volume":"101","author":"Cao","year":"2022","journal-title":"Med (Baltimore)"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.702908","article-title":"Controlling nutritional status score before receiving treatment as a prognostic indicator for patients with urothelial cancer: an exploration evaluation methods","volume":"11","author":"Peng","year":"2021","journal-title":"Front Oncol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1275033\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T23:27:17Z","timestamp":1700436437000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1275033\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,20]]},"references-count":40,"alternative-id":["10.3389\/fimmu.2023.1275033"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2023.1275033","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,20]]},"article-number":"1275033"}}